Results 101 to 110 of about 8,676,773 (167)

Mortality in narcolepsy and other sleep clinic patients: a 25-year propensity-matched VA cohort study. [PDF]

J Clin Sleep Med
Sharafkhaneh A, Dauvilliers Y, BaHammam AS, Azarian M, Thorpy M, Han F, Senel GB, Aksu M, Razjouyan J.   +8 more
europepmc   +1 more source

Pharmacologic treatment of fibromyalgia: an update. [PDF]

Front Pharmacol
Li Y, Li Y, Wu S, Long M, Chen X, Wang Y, Zhao J, Zhao J, He B, Chang C, Jiao J.   +10 more
europepmc   +1 more source

Prescription Drugs Subject to a Risk Evaluation and Mitigation Strategy: Patient Perspectives on Risk Communication and the Value of Educational Materials. [PDF]

Drug Saf
Chimonas S, Cosenza C, Kesselheim AS, Toyserkani GA, Oswell KH, LaCivita C, Dal Pan GJ, Sarpatwari A.   +7 more
europepmc   +1 more source

Endogenous Levels, Detection Time, and Symptoms of Gamma-Hydroxybutyric Acid: Results From a Placebo-Controlled Clinical Trial. [PDF]

Basic Clin Pharmacol Toxicol
Faldborg KB, Sørensen LK, Hasselstrøm JB, Andersen CU.   +3 more
europepmc   +1 more source

Safety signals for drug-related respiratory depression: a disproportionality analysis of the FDA Adverse Event Reporting System (FAERS). [PDF]

J Thorac Dis
Rui Y, Chen Z, Zhou J.
europepmc   +1 more source

Sodium Oxybate: Practical Considerations and Patient Perspectives. [PDF]

CNS Drugs
Lavender M, Martin C, Anderson D.
europepmc   +1 more source

Comparative efficacy of new wake-promoting agents for narcolepsy-a network meta-analysis. [PDF]

BMC Neurol
Yan Z, Li J, Yu Y, Qiu S, Wang B, Tang J.   +5 more
europepmc   +1 more source

Therapeutic Use of γ-Hydroxybutyrate: History and Clinical Utility of Oxybates and Considerations of Once- and Twice-Nightly Dosing in Narcolepsy. [PDF]

CNS Drugs
Roth T.
europepmc   +1 more source

Treatments for enhancing sleep quality in fibromyalgia: a systematic review and meta-analysis. [PDF]

Rheumatology (Oxford)
Pathak A, Kelleher EM, Brennan I, Amarnani R, Wall A, Murphy R, Lee H, Fordham B, Irani A.   +8 more
europepmc   +1 more source

A case study of acceptance and commitment therapy for central disorders of hypersomnolence: opportunities to improve patient-centered and comprehensive treatment approaches. [PDF]

J Clin Sleep Med
Roth AJ, Foldvary-Schaefer N.
europepmc   +1 more source